Cognitive Protection - Dexmedetomidine and Cognitive Reserve
Sponsor: Icahn School of Medicine at Mount Sinai
Terminated
Pilot study initiated to provide support data for main grant GCO 06-0217 funded. only baseline characteristic data collected. no results for this study.
Other terminated trials from Icahn School of Medicine at Mount Sinai
- Migraine Headaches · Feb 2026
- Coronary Artery Disease · Phase NA · Oct 2025
- CTCL · Phase PHASE2 · Jun 2025
- Peripartum Anemia · Phase NA · Jun 2025
- Pleural Disease · Phase PHASE3 · Mar 2025
See all terminations from Icahn School of Medicine at Mount Sinai
A PHASE4 clinical study on PD and POCD, this trial is terminated or withdrawn. The trial is conducted by Icahn School of Medicine at Mount Sinai and has accumulated 11 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 6 earlier versions
-
Aug 2019 — Nov 2020 [monthly]
Terminated PHASE4
-
Jun 2018 — Aug 2019 [monthly]
Terminated PHASE4
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE4
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE4
-
Feb 2017 — Aug 2017 [monthly]
Terminated PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Sep 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai
For direct contact, visit the study record on ClinicalTrials.gov .